Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDCTP longitudinal malaria treatment study
PACTR201105000286876Recruiting
- Sponsor
- Université des Sciences, des Techniques et des Technologies de Bamako
- Start
- Jun 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Trial of dihydroartemisinin, pyronaridine and lumefantrine in malaria (4 arms), sponsored by Université des Sciences, des Techniques et des Technologies de Bamako. Primary endpoint: Incidence rate of malaria and repeated treatment safety over 2 years. Started Jun 2011; status: recruiting.
02
Drugs
dihydroartemisininpyronaridinelumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201105000286876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201105000286876.